 Joaquin Espinosa
Concepts (328)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 25 | 2025 | 469 | 7.220 |
Why?
| | Tumor Suppressor Protein p53 | 16 | 2025 | 508 | 4.270 |
Why?
| | Transcription, Genetic | 12 | 2021 | 1404 | 2.170 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 130 | 1.990 |
Why?
| | Neoplasms | 10 | 2025 | 2464 | 1.790 |
Why?
| | Transcriptional Activation | 6 | 2023 | 356 | 1.650 |
Why?
| | Janus Kinase Inhibitors | 2 | 2024 | 25 | 1.640 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 1.540 |
Why?
| | Piperidines | 2 | 2024 | 190 | 1.470 |
Why?
| | Pyrimidines | 3 | 2024 | 445 | 1.390 |
Why?
| | Proteome | 4 | 2024 | 430 | 1.380 |
Why?
| | Transcriptome | 4 | 2024 | 881 | 1.280 |
Why?
| | Interferons | 4 | 2023 | 192 | 1.220 |
Why?
| | Hypoxia | 2 | 2024 | 1036 | 0.990 |
Why?
| | Antineoplastic Agents | 5 | 2025 | 2051 | 0.960 |
Why?
| | Gene Regulatory Networks | 2 | 2021 | 280 | 0.960 |
Why?
| | Immunoglobulins | 1 | 2025 | 157 | 0.910 |
Why?
| | Erythropoiesis | 1 | 2024 | 51 | 0.910 |
Why?
| | Heme | 1 | 2024 | 76 | 0.880 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 127 | 0.880 |
Why?
| | Receptors, Interferon | 2 | 2023 | 50 | 0.860 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1351 | 0.830 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.820 |
Why?
| | Transcription Factors | 9 | 2023 | 1628 | 0.770 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 385 | 0.760 |
Why?
| | Blood | 1 | 2022 | 99 | 0.750 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 20 | 0.750 |
Why?
| | Cell Death | 1 | 2022 | 348 | 0.720 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 86 | 0.710 |
Why?
| | Oncogenes | 1 | 2021 | 109 | 0.690 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 6 | 2025 | 63 | 0.690 |
Why?
| | Databases, Genetic | 1 | 2021 | 228 | 0.670 |
Why?
| | Kynurenine | 2 | 2023 | 105 | 0.670 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 740 | 0.670 |
Why?
| | Trisomy | 2 | 2019 | 77 | 0.660 |
Why?
| | Apoptosis | 10 | 2023 | 2435 | 0.650 |
Why?
| | Interferon-alpha | 2 | 2020 | 192 | 0.640 |
Why?
| | Signal Transduction | 9 | 2024 | 4826 | 0.640 |
Why?
| | Humans | 61 | 2025 | 128417 | 0.620 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 313 | 0.610 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 176 | 0.610 |
Why?
| | Cyclin-Dependent Kinase 8 | 6 | 2022 | 44 | 0.610 |
Why?
| | Metabolome | 1 | 2021 | 319 | 0.590 |
Why?
| | Genomics | 1 | 2021 | 715 | 0.500 |
Why?
| | Case-Control Studies | 6 | 2025 | 3328 | 0.460 |
Why?
| | Cell Proliferation | 6 | 2023 | 2344 | 0.460 |
Why?
| | Cell Line, Tumor | 9 | 2023 | 3184 | 0.460 |
Why?
| | Animals | 20 | 2025 | 34479 | 0.450 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2024 | 257 | 0.440 |
Why?
| | Proteomics | 4 | 2025 | 1009 | 0.430 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 620 | 0.420 |
Why?
| | Cyclins | 3 | 2022 | 85 | 0.400 |
Why?
| | Mice | 14 | 2024 | 16602 | 0.400 |
Why?
| | Datasets as Topic | 2 | 2022 | 109 | 0.370 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 577 | 0.350 |
Why?
| | RNA Polymerase II | 4 | 2019 | 317 | 0.350 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2019 | 191 | 0.350 |
Why?
| | Adult | 9 | 2025 | 35299 | 0.320 |
Why?
| | Mediator Complex | 3 | 2022 | 56 | 0.310 |
Why?
| | Female | 19 | 2025 | 68153 | 0.300 |
Why?
| | Gene Expression Profiling | 3 | 2024 | 1688 | 0.300 |
Why?
| | Biomarkers | 4 | 2025 | 3880 | 0.290 |
Why?
| | Promoter Regions, Genetic | 4 | 2013 | 1198 | 0.280 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 634 | 0.270 |
Why?
| | Gene Expression Regulation | 3 | 2012 | 2505 | 0.270 |
Why?
| | Adolescent | 6 | 2025 | 20179 | 0.270 |
Why?
| | Cytokines | 5 | 2024 | 1983 | 0.260 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2006 | 29 | 0.250 |
Why?
| | Cell Differentiation | 2 | 2024 | 1900 | 0.250 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2009 | 114 | 0.250 |
Why?
| | Cell Cycle | 2 | 2008 | 581 | 0.250 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2328 | 0.250 |
Why?
| | Metabolomics | 2 | 2021 | 599 | 0.240 |
Why?
| | Phosphorylation | 4 | 2022 | 1681 | 0.240 |
Why?
| | Male | 11 | 2025 | 62857 | 0.240 |
Why?
| | Protein Binding | 5 | 2021 | 2103 | 0.230 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 13 | 0.220 |
Why?
| | Young Adult | 4 | 2025 | 12312 | 0.220 |
Why?
| | Erythropoietin | 1 | 2024 | 84 | 0.210 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 490 | 0.210 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 184 | 0.210 |
Why?
| | Glutamine | 1 | 2023 | 92 | 0.210 |
Why?
| | Liposarcoma | 1 | 2023 | 27 | 0.210 |
Why?
| | Cell Line | 4 | 2019 | 2731 | 0.210 |
Why?
| | Alzheimer Disease | 2 | 2020 | 516 | 0.210 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.210 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 26 | 0.200 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 90 | 0.200 |
Why?
| | Child, Preschool | 4 | 2025 | 10384 | 0.200 |
Why?
| | Growth Disorders | 1 | 2022 | 80 | 0.200 |
Why?
| | Centrosome | 2 | 2022 | 64 | 0.200 |
Why?
| | Gene Silencing | 1 | 2023 | 185 | 0.190 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 156 | 0.190 |
Why?
| | DNA-Binding Proteins | 3 | 2016 | 1421 | 0.190 |
Why?
| | Medulloblastoma | 1 | 2023 | 198 | 0.190 |
Why?
| | Acetyltransferases | 1 | 2001 | 22 | 0.180 |
Why?
| | Stress, Physiological | 1 | 2024 | 410 | 0.180 |
Why?
| | Doxorubicin | 3 | 2007 | 322 | 0.180 |
Why?
| | Hematopoiesis | 2 | 2021 | 185 | 0.180 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 24 | 0.180 |
Why?
| | Cilia | 2 | 2022 | 179 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.180 |
Why?
| | Azetidines | 1 | 2020 | 40 | 0.180 |
Why?
| | Models, Biological | 1 | 2008 | 1691 | 0.170 |
Why?
| | RNA, Messenger | 3 | 2021 | 2675 | 0.170 |
Why?
| | Up-Regulation | 2 | 2021 | 825 | 0.170 |
Why?
| | Flow Cytometry | 2 | 2019 | 1142 | 0.170 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 307 | 0.170 |
Why?
| | Data Mining | 1 | 2021 | 109 | 0.170 |
Why?
| | MicroRNAs | 2 | 2018 | 677 | 0.170 |
Why?
| | Nuclear Proteins | 3 | 2023 | 657 | 0.170 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 252 | 0.170 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.170 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 318 | 0.170 |
Why?
| | Child | 6 | 2025 | 20655 | 0.170 |
Why?
| | Connective Tissue Diseases | 1 | 2020 | 81 | 0.170 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 23 | 0.160 |
Why?
| | Heart Diseases | 1 | 2023 | 345 | 0.160 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 52 | 0.160 |
Why?
| | Protein Domains | 2 | 2017 | 252 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 5272 | 0.150 |
Why?
| | Coinfection | 1 | 2020 | 131 | 0.150 |
Why?
| | Middle Aged | 5 | 2025 | 30889 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 391 | 0.150 |
Why?
| | Calcinosis | 1 | 2020 | 230 | 0.150 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 58 | 0.150 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 32 | 0.150 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 15 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2024 | 1032 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 380 | 0.150 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 90 | 0.150 |
Why?
| | Bacterial Infections | 1 | 2020 | 226 | 0.150 |
Why?
| | Inflammation | 2 | 2020 | 2654 | 0.150 |
Why?
| | Stem Cell Niche | 1 | 2018 | 51 | 0.150 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 61 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 465 | 0.140 |
Why?
| | Cell Survival | 1 | 2021 | 1077 | 0.140 |
Why?
| | Autoimmunity | 1 | 2023 | 860 | 0.140 |
Why?
| | Binding Sites | 3 | 2014 | 1236 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 249 | 0.140 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 182 | 0.140 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.140 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 187 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 872 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 499 | 0.130 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1923 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2017 | 72 | 0.130 |
Why?
| | Antigens | 1 | 2018 | 353 | 0.130 |
Why?
| | Exosomes | 1 | 2017 | 96 | 0.130 |
Why?
| | Chromatin | 4 | 2016 | 477 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 162 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 759 | 0.130 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 958 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 161 | 0.120 |
Why?
| | HCT116 Cells | 3 | 2019 | 78 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 242 | 0.120 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 77 | 0.120 |
Why?
| | Autophagy | 1 | 2018 | 265 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2023 | 3937 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 378 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 567 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2017 | 229 | 0.120 |
Why?
| | Phenotype | 1 | 2023 | 3044 | 0.120 |
Why?
| | Azepines | 1 | 2015 | 88 | 0.120 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 386 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1456 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 935 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 399 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 732 | 0.110 |
Why?
| | Acetylation | 2 | 2007 | 237 | 0.110 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2013 | 13 | 0.110 |
Why?
| | Mitogens | 1 | 2013 | 58 | 0.110 |
Why?
| | Disease Progression | 1 | 2021 | 2602 | 0.110 |
Why?
| | Down-Regulation | 1 | 2015 | 631 | 0.110 |
Why?
| | Prospective Studies | 1 | 2025 | 7036 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 163 | 0.100 |
Why?
| | Feedback, Physiological | 1 | 2012 | 74 | 0.100 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 930 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1745 | 0.100 |
Why?
| | RNA Stability | 1 | 2012 | 100 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2006 | 835 | 0.090 |
Why?
| | Sirtuins | 1 | 2010 | 37 | 0.080 |
Why?
| | HeLa Cells | 3 | 2013 | 603 | 0.080 |
Why?
| | Histones | 2 | 2007 | 586 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 431 | 0.080 |
Why?
| | S Phase | 1 | 2009 | 73 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2429 | 0.080 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2008 | 799 | 0.080 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2008 | 21 | 0.080 |
Why?
| | Hydroxyurea | 2 | 2023 | 31 | 0.070 |
Why?
| | RNA | 1 | 2014 | 880 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 147 | 0.070 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2007 | 43 | 0.070 |
Why?
| | Formaldehyde | 1 | 2007 | 57 | 0.070 |
Why?
| | Radiation, Ionizing | 1 | 2007 | 75 | 0.070 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1336 | 0.070 |
Why?
| | Glycolysis | 2 | 2024 | 293 | 0.070 |
Why?
| | Protein Kinases | 1 | 2009 | 309 | 0.070 |
Why?
| | RNA Precursors | 1 | 2007 | 147 | 0.070 |
Why?
| | Fluorouracil | 1 | 2007 | 197 | 0.070 |
Why?
| | Transcription Factors, TFII | 1 | 2006 | 40 | 0.060 |
Why?
| | Kinetics | 2 | 2007 | 1615 | 0.060 |
Why?
| | High Mobility Group Proteins | 1 | 2006 | 42 | 0.060 |
Why?
| | Transcriptional Elongation Factors | 1 | 2006 | 36 | 0.060 |
Why?
| | Transcription Factor TFIIH | 1 | 2006 | 40 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2132 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 131 | 0.060 |
Why?
| | Protein Transport | 1 | 2007 | 420 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2019 | 2755 | 0.060 |
Why?
| | Serine | 1 | 2006 | 135 | 0.060 |
Why?
| | Glucose | 1 | 2010 | 982 | 0.060 |
Why?
| | Protein Isoforms | 1 | 2006 | 378 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 814 | 0.060 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 18 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 940 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 56 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 27 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 20 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 44 | 0.050 |
Why?
| | L-Selectin | 1 | 2023 | 24 | 0.050 |
Why?
| | Proline | 1 | 2023 | 76 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2023 | 44 | 0.050 |
Why?
| | Perforin | 1 | 2023 | 19 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 217 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 45 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 145 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 168 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 248 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 194 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 199 | 0.050 |
Why?
| | Centrioles | 1 | 2022 | 41 | 0.050 |
Why?
| | DNA Footprinting | 1 | 2001 | 33 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 142 | 0.050 |
Why?
| | Neuroimaging | 1 | 2024 | 278 | 0.050 |
Why?
| | p300-CBP Transcription Factors | 1 | 2001 | 21 | 0.050 |
Why?
| | Immunoblotting | 1 | 2001 | 300 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 38 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2001 | 63 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 138 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2018 | 4001 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 267 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 179 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 140 | 0.040 |
Why?
| | Genetic Testing | 1 | 2022 | 428 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 16 | 0.040 |
Why?
| | Purines | 1 | 2020 | 169 | 0.040 |
Why?
| | Microtubules | 1 | 2022 | 259 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 309 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 587 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 295 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 70 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2001 | 217 | 0.040 |
Why?
| | Heart | 1 | 2023 | 635 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 9704 | 0.040 |
Why?
| | DNA | 1 | 2006 | 1390 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2018 | 7 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 26 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 634 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 79 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 350 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2018 | 115 | 0.040 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 46 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 211 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2062 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 404 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 586 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 27 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 846 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2264 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 1046 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 608 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 346 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 178 | 0.030 |
Why?
| | Imidazoles | 1 | 2017 | 226 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 71 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1228 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 406 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 424 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 125 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 55 | 0.030 |
Why?
| | Piperazines | 1 | 2017 | 336 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 802 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 307 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1869 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 18 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 936 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 852 | 0.030 |
Why?
| | Genes, ras | 1 | 2013 | 98 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 141 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2018 | 817 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2017 | 961 | 0.030 |
Why?
| | Liver | 1 | 2020 | 1826 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1181 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1705 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 683 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3772 | 0.020 |
Why?
| | Cell Respiration | 1 | 2010 | 98 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2010 | 48 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4892 | 0.020 |
Why?
| | Daunorubicin | 1 | 2009 | 25 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2009 | 23 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2009 | 16 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2009 | 31 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 64 | 0.020 |
Why?
| | Caffeine | 1 | 2009 | 61 | 0.020 |
Why?
| | Coenzymes | 1 | 2008 | 17 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 12 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 31 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 365 | 0.020 |
Why?
| | Genes, myc | 1 | 2007 | 50 | 0.020 |
Why?
| | Poly A | 1 | 2007 | 48 | 0.020 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2007 | 24 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 225 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 281 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 14454 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2008 | 659 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1281 | 0.020 |
Why?
| | Infant | 1 | 2017 | 8914 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 492 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 3689 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1480 | 0.010 |
Why?
|
|
Espinosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|